EMBRYON TRANSFER CATHETERS/SETS

K994327 · Rocket Medical Plc · MQF · Feb 28, 2000 · Obstetrics/Gynecology

Device Facts

Record IDK994327
Device NameEMBRYON TRANSFER CATHETERS/SETS
ApplicantRocket Medical Plc
Product CodeMQF · Obstetrics/Gynecology
Decision DateFeb 28, 2000
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 884.6110
Device ClassClass 2
AttributesTherapeutic

Intended Use

The EMBRYON™ Embryo Transfer Catheters / Sets are used to place human embryos into the uterine cavity.

Device Story

EMBRYON™ Embryo Transfer Catheters/Sets are medical devices used by clinicians during in vitro fertilization (IVF) procedures. The device facilitates the placement of human embryos into the uterine cavity. It is a mechanical catheter system designed for clinical use. The device has been distributed internationally for up to 10 years prior to this submission. It functions as a delivery tool for reproductive procedures.

Clinical Evidence

No clinical data provided. The device relies on design evaluation, a Quality Assurance Program, and a history of commercial distribution in the UK and other countries for up to 10 years.

Technological Characteristics

Mechanical catheter system for embryo transfer. Materials and design are stated to be equivalent to the predicate device. No specific material standards or electronic components described.

Indications for Use

Indicated for the transfer of human embryos into the uterine cavity during IVF procedures. For prescription use only.

Regulatory Classification

Identification

Assisted reproduction catheters are devices used in in vitro fertilization (IVF), gamete intrafallopian transfer (GIFT), or other assisted reproduction procedures to introduce or remove gametes, zygote(s), preembryo(s), and/or embryo(s) into or from the body. This generic type of device may include catheters, cannulae, introducers, dilators, sheaths, stylets, and component parts.

Special Controls

*Classification.* Class II (special controls) (mouse embryo assay information, endotoxin testing, sterilization validation, design specifications, labeling requirements, biocompatibility testing, and clinical testing).

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ FEB 28 "(1000 2994327 ## 510(k) Summary of Safety and Effectiveness Trade name: Proposed Classification name: EMBRYON™ Embryo Transfer Catheters / Sets Assisted Reproduction Catheters Class II 85 MOF These class II devices, registered by Rocket Medical plc. (Establishment number: 8010022/9610632) have been the subject of a reclassification by FDA. The EMBRYON™ Embryo Transfer Catheters / Sets are substantially equivalent to the Cook OB/GYN Embryo transfer catheters / sets in terms of indications for use, design, construction and materials equivalence. FDA found these devices substantially equivalent in December 1998 on #K983594. The EMBRYON™ Embryo Transfer Catheters / Sets are used for transferring embryos into uterine cavity during IVF procedures. The devices we believe are safe and effective for the application for which they are intended, for transferring embryos into the uterine cavity, having been subjected to full design evaluation and a full Ouality Assurance Program. They have been on sale and in commercial distribution within the UK and many other countries for up to10 years. Rocket Medical plc., will continue to search all appropriate sources for information relating to safety and effectiveness and maintain an in-house reporting system to identify adverse safety and effectiveness information and as such, applicable data will be recorded for this product. ## CERTIFICATION I hereby certify that this Summary of Safety and Effectiveness applies for the above indicated device. 16/12/99 Date 16222 Signed by Leslie Todd Quality Assurance & Regulatory Affairs Manager Rocket Medical plc Wear Industrial Estate, Washington Tyne & Wear, England. NE37 1NE {1}------------------------------------------------ Image /page/1/Picture/2 description: The image shows the logo for the Department of Health & Human Services - USA. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized emblem featuring three abstract shapes resembling human profiles or flowing lines, stacked on top of each other. FEB 2 8 2000 Mr. Les Todd Quality Assurance & Regulatory Affairs Manager Rocket Medical PLC Wear Industrial Estate Washington. Tyne & Wear, NE37 INE. UNITED KINGDOM Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Re: K994327 EMBRYON™ Embryo Transfer Catheters/Sets Dated: December 15, 1999 Received: December 22, 1999 Regulatory Class: Il 21 CFR §884.6110/Procode: 85 MQF Dear Mr. Todd: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4591. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the requlation entitled, "Misbranding by reference to premarket notification" (21CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html". Sincerely yours, Daniel G. Schultz, M.D. Captain, USPHS Acting Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure(s) {2}------------------------------------------------ 510(k) Number : Not yet assigned EMBRYON™ Embryo Transfer Catheters / Sets Device Name: Indications for Use: The EMBRYON™ Embryo Transfer Catheters / Sets are used to place human embryos into the uterine cavity. (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use (Per 21 CFR 801.109) the text is the following: 21 of 23 Rocketmedical
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...